title: More on crizotinib.
authors.forename: Jan M
authors.initials: JM
authors.lastname: Orenstein
mesh_terms: D000077548:Anaplastic Lymphoma Kinase; D000077547:Crizotinib; D006104:Granuloma, Plasma Cell / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D009154:Mutation; D058628:Myofibroblasts / Q000473:pathology / Q000648:ultrastructure*; D009379:Neoplasms, Muscle Tissue / Q000188:drug therapy / Q000473:pathology*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000235:genetics; D011720:Pyrazoles / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D020794:Receptor Protein-Tyrosine Kinases
chemical_list: D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011725:Pyridines; D000077547:Crizotinib; D000077548:Anaplastic Lymphoma Kinase; D011505:Protein-Tyrosine Kinases; D020794:Receptor Protein-Tyrosine Kinases